tradingkey.logo

American Well Corp

AMWL
5.050USD
-0.040-0.79%
Close 11/04, 16:00ETQuotes delayed by 15 min
81.25MMarket Cap
LossP/E TTM

American Well Corp

5.050
-0.040-0.79%

More Details of American Well Corp Company

American Well Corporation operates a hybrid care delivery enablement platform in the United States and globally, connecting providers, payers, patients and innovators. The Company offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke and acute psychiatry evaluations to virtual nursing and e-sitting. For health plans, employers and government entities, its enterprise platform enables a broad set of use cases, including primary, urgent, mental health, specialty, and chronic care. Its virtual primary care solution offers a primary care navigation hub. It offers new tailored healthcare solutions for government clients that provide care options to meet the diverse needs of government healthcare systems, personnel, and their families.

American Well Corp Info

Ticker SymbolAMWL
Company nameAmerican Well Corp
IPO dateSep 17, 2020
CEOMr. Ido Schoenberg, M.D.
Number of employees877
Security typeOrdinary Share
Fiscal year-endSep 17
Address75 State Street
CityBOSTON
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code02109
Phone16172053500
Websitehttps://business.amwell.com/
Ticker SymbolAMWL
IPO dateSep 17, 2020
CEOMr. Ido Schoenberg, M.D.

Company Executives of American Well Corp

Name
Name/Position
Position
Shareholding
Change
Dr. Roy Schoenberg, M.D.
Dr. Roy Schoenberg, M.D.
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
133.30K
+23.08%
Mr. Ido Schoenberg, M.D.
Mr. Ido Schoenberg, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
114.25K
+77.82%
Dr. Peter L. Slavin, M.D.
Dr. Peter L. Slavin, M.D.
Independent Director
Independent Director
44.47K
+88.60%
Mr. Derek Ross
Mr. Derek Ross
Independent Director
Independent Director
29.49K
+242.86%
Ms. Deborah C. Jackson
Ms. Deborah C. Jackson
Independent Director
Independent Director
12.54K
-41.94%
Mr. Dmitry (Dan) Zamansky
Mr. Dmitry (Dan) Zamansky
Chief Product and Technology Officer
Chief Product and Technology Officer
2.47K
--
Dr. Delos Marshall (Toby) Cosgrove, M.D.
Dr. Delos Marshall (Toby) Cosgrove, M.D.
Independent Director
Independent Director
--
--
Mr. Mark Hirschhorn
Mr. Mark Hirschhorn
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
--
--
Ms. Phyllis I. Gotlib
Ms. Phyllis I. Gotlib
President, American Well International
President, American Well International
--
--
Ms. Rivka R. (Ricky) Goldwasser
Ms. Rivka R. (Ricky) Goldwasser
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Roy Schoenberg, M.D.
Dr. Roy Schoenberg, M.D.
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
133.30K
+23.08%
Mr. Ido Schoenberg, M.D.
Mr. Ido Schoenberg, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
114.25K
+77.82%
Dr. Peter L. Slavin, M.D.
Dr. Peter L. Slavin, M.D.
Independent Director
Independent Director
44.47K
+88.60%
Mr. Derek Ross
Mr. Derek Ross
Independent Director
Independent Director
29.49K
+242.86%
Ms. Deborah C. Jackson
Ms. Deborah C. Jackson
Independent Director
Independent Director
12.54K
-41.94%
Mr. Dmitry (Dan) Zamansky
Mr. Dmitry (Dan) Zamansky
Chief Product and Technology Officer
Chief Product and Technology Officer
2.47K
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Platform Subscription
40.46M
57.07%
Visits
22.75M
32.09%
Other
7.69M
10.84%
By RegionUSD
Name
Revenue
Proportion
United States
70.90M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Platform Subscription
40.46M
57.07%
Visits
22.75M
32.09%
Other
7.69M
10.84%

Shareholding Stats

Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Senvest Management, LLC
9.05%
Morgan Stanley & Co. LLC
8.44%
Caledonia (Private) Investments Pty Limited
5.58%
The Vanguard Group, Inc.
4.37%
Alerce Investment Management, L.P.
3.61%
Other
68.95%
Shareholders
Shareholders
Proportion
Senvest Management, LLC
9.05%
Morgan Stanley & Co. LLC
8.44%
Caledonia (Private) Investments Pty Limited
5.58%
The Vanguard Group, Inc.
4.37%
Alerce Investment Management, L.P.
3.61%
Other
68.95%
Shareholder Types
Shareholders
Proportion
Investment Advisor
14.69%
Hedge Fund
11.93%
Research Firm
9.18%
Individual Investor
5.07%
Investment Advisor/Hedge Fund
4.45%
Private Equity
3.61%
Corporation
0.54%
Sovereign Wealth Fund
0.19%
Pension Fund
0.05%
Other
50.31%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
291
6.40M
44.14%
-1.95M
2025Q2
331
7.42M
51.14%
-1.66M
2025Q1
349
7.29M
51.54%
-1.83M
2024Q4
358
7.65M
54.80%
-1.30M
2024Q3
371
7.45M
54.59%
-1.39M
2024Q2
383
8.06M
60.42%
-1.29M
2024Q1
405
8.42M
64.02%
-956.28K
2023Q4
418
8.05M
63.03%
-798.02K
2023Q3
431
8.26M
67.90%
-1.19M
2023Q2
440
8.42M
67.58%
-997.87K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Senvest Management, LLC
1.31M
9.05%
+4.50K
+0.34%
Jun 30, 2025
Morgan Stanley & Co. LLC
1.22M
8.44%
-1.44K
-0.12%
Jun 30, 2025
Caledonia (Private) Investments Pty Limited
808.76K
5.58%
-1.51K
-0.19%
Jun 30, 2025
The Vanguard Group, Inc.
634.30K
4.37%
+2.16K
+0.34%
Jun 30, 2025
Alerce Investment Management, L.P.
523.78K
3.61%
--
--
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
201.54K
1.39%
-4.07K
-1.98%
Jun 30, 2025
Acadian Asset Management LLC
190.59K
1.31%
+2.37K
+1.26%
Jun 30, 2025
Renaissance Technologies LLC
175.42K
1.21%
+500.00
+0.29%
Jun 30, 2025
Rock Point Advisors, LLC
173.59K
1.2%
+32.84K
+23.34%
Jun 30, 2025
Geode Capital Management, L.L.C.
147.56K
1.02%
-11.65K
-7.32%
Jun 30, 2025
View more

Related ETFs

Updated: Sun, Nov 2
Updated: Sun, Nov 2
Name
Proportion
Global X Millennial Consumer ETF
0%
Langar Global HealthTech ETF
0%
iShares U.S. Healthcare Providers ETF
0%
ProShares UltraPro Russell2000
0%
Fidelity Digital Health ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Global X HealthTech ETF
0%
Schwab U.S. Broad Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Global X Russell 2000 ETF
0%
View more
Global X Millennial Consumer ETF
Proportion0%
Langar Global HealthTech ETF
Proportion0%
iShares U.S. Healthcare Providers ETF
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
Fidelity Digital Health ETF
Proportion0%
Global X Russell 2000 Covered Call ETF
Proportion0%
Global X HealthTech ETF
Proportion0%
Schwab U.S. Broad Market ETF
Proportion0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Jun 28, 2024
Merger
20→1
Jun 28, 2024
Merger
20→1
Jun 28, 2024
Merger
20→1
Jun 28, 2024
Merger
20→1
Date
Type
Ratio
Jun 28, 2024
Merger
20→1
Jun 28, 2024
Merger
20→1
Jun 28, 2024
Merger
20→1
Jun 28, 2024
Merger
20→1
KeyAI